false 0000803578 0000803578 2024-12-27 2024-12-27
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K 
CURRENT REPORT
 
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): December 27, 2024
 
 
FIREFLY NEUROSCIENCE, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
  
001-41092
  
54-1167364
(State or other jurisdiction
of incorporation)
  
(Commission File Number)
  
(IRS Employer
Identification No.)
 
1100 Military Road, Kenmore, NY
  
14217
(Address of principal executive offices)
  
(Zip Code)
 
(888) 237-6412
(Registrant’s telephone number, including area code)
 
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  ☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  ☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  ☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading Symbol(s)
  
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
  
AIFF
  
The Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.                            
Emerging Growth Company ☐
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
Item 5.07 Submission of Matters to a Vote of Security Holders.
 
On December 27, 2024, the Company held the Annual Meeting. As of November 15, 2024, the record date for the Annual Meeting, there were 8,503,365 shares of common stock issued and outstanding and entitled to vote on the proposals presented at the Annual Meeting, of which 3,787,219 shares were present in person or represented by proxy, which constituted a quorum. The holders of shares of the Company’s common stock are entitled to one vote for each share held. The proposals are described in greater detail in the Proxy Statement, the relevant portions of which are incorporated by reference herein. Set forth below are the final voting results for each of the proposals submitted to a vote of the Company’s stockholders at the Annual Meeting.
 
(i) A proposal to elect three (3) Class I directors to the Board of Directors (the “Board”) to serve until the annual meeting of stockholders to be held in 2027, or until each one’s respective successor has been duly elected and qualified. The proposal was approved as set forth below:
 
Nominee
  
For
    
Withheld
    
Broker
Non-Votes
  
David DeCaprio
    
3,303,635
      
2,596
      
480,988
  
Jon Olsen
    
674,301
      
2,631,930
      
480,988
  
Greg Lipschitz
    
3,289,836
      
16,395
      
480,988
  
 
(ii) A proposal to ratify the appointment of Marcum Canada, LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2024. The proposal was approved as set forth below:
 
For
  
Against
  
Abstain
  
3,756,71
  
3,500
  
27,008
  
 
(iii) A proposal to approve, on a non-binding, advisory basis, the compensation paid to our named executive officers. The proposal was approved as set forth below:
 
For
  
Against
  
Abstain
  
Broker Non-Votes
3,113,215
  
191,466
  
1,550
  
480,988
 
(iv) A proposal to approve, on a non-binding, advisory basis, the frequency of holding a vote on executive compensation. The result of the proposal was as set forth below:
 
3 Years
  
2 Years
  
1 Year
  
Abstain
  
Broker Non-Votes
1,239,044
  
22,176
  
2,036,208
  
8,803
  
480,988
 
Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits
 
Exhibit
No.
  
Description of Exhibit
104
  
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Date: December 27, 2024
FIREFLY NEUROSCIENCE, INC.
   
 
/s/ Jon Olsen
 
Name: Jon Olsen
 
Title: Chief Executive Officer
 
 
 
v3.24.4
Document And Entity Information
Dec. 27, 2024
Document Information [Line Items]  
Entity, Registrant Name FIREFLY NEUROSCIENCE, INC.
Document, Type 8-K
Document, Period End Date Dec. 27, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-41092
Entity, Tax Identification Number 54-1167364
Entity, Address, Address Line One 1100 Military Road
Entity, Address, City or Town Kenmore
Entity, Address, State or Province NY
Entity, Address, Postal Zip Code 14217
City Area Code 888
Local Phone Number 237-6412
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol AIFF
Security Exchange Name NASDAQ
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000803578
Firefly Neuroscience (NASDAQ:AIFF)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025 Haga Click aquí para más Gráficas Firefly Neuroscience.
Firefly Neuroscience (NASDAQ:AIFF)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025 Haga Click aquí para más Gráficas Firefly Neuroscience.